Forest Laboratories Settles $300M Fraud Case

Forest Laboratories agreed to a $300 million settlement following allegations of off-label marketing lawsuit and illegal kickbacks. The lawsuit, which included $106 million in civil recovery, was brought by a whistleblower sales representative who exposed unethical sales practices.

Off-Label Marketing & Kickback Scheme

The whistleblower, a former Forest sales representative, revealed that the company pressured sales staff to promote antidepressants for pediatric use, even though the drugs were not FDA-approved for children. Additionally, Forest Laboratories allegedly provided illegal kickbacks to incentivize physicians to prescribe these medications, violating federal law.

This case remains a landmark off-label marketing lawsuit, reinforcing the importance of whistleblowers in exposing pharmaceutical fraud. Read more about this case here.

Report Fraud at No Cost

If you have information about fraudulent practices, contact our office for a free, confidential consultation:

• Fill out our consultation form by clicking here.
• Email us at info@wilbanksgouinlock.com.
• Call (404) 842-1075, ext. 123 or 122.

This article is for informational purposes only and should not be considered legal advice.